fda tirzepatide compound update says that the GLP-1 shortage is over Compounding pharmacies can resume making
Description
Recent Findings Retatrutide is the first triple agonist (acting on GLP-1/GIP/glucagon receptors) with published phase 2 data in people with obesity as well as in people with T2D

Shop used pro audio, lighting, video, and staging gear for sale on Gearsupply.com

BCBSM made a major announcement yesterday regarding GLP-1 coverage

LifeMD becomes the first GLP-1 virtual primary care provider to employ the Withings Rx-based, at-home Body Pro 2 scale, as well as its BPM Connect Pro blood pressure monitor.

What's good for your gut is good for you